is a proven operational leader with more than 25 years of experience building and operating leading biotech companies.
Mr. Starr co-founded Third Rock Ventures in 2007 and focuses on the formation, development and business strategy of the firm's portfolio companies as well as actively identifying and evaluating new investments.
In addition to his role at Third Rock, he also serves as the interim chief executive officer of SAGE Therapeutics.
Prior to Third Rock Ventures, Mr. Starr was chief operating officer and chief financial officer at Millennium Pharmaceuticals, where he led key roles in raising billions of dollars in capital through strategic alliances and public financing and driving growth through company expansion and mergers and acquisitions.
Earlier in his career, he served in various executive roles at Millennium BioTherapeutics, Biogen and Digital Equipment Corporation.
He is currently a board member of Alnylam Pharmaceuticals and SAGE Therapeutics.
Mr. Starr holds a M.S. in corporate finance from Boston College and a B.A. in mathematics and business from Colby College.